StonvexLoading…
StonvexStonvexStonvexCore line items from BMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.49B | $48.19B | $35.69B | $23.47B |
Operating Income | $3.24B | $9.33B | $7.86B | $4.74B |
Net Income | $2.68B | $7.05B | $5.97B | $3.77B |
EPS (Diluted) | $1.31 | $3.46 | $2.93 | $1.85 |
Total Assets | $86.48B | $90.04B | $96.89B | $94.68B |
Total Liabilities | $66.37B | $71.53B | $78.29B | $77.19B |
Cash & Equivalents | $9.57B | $10.21B | $15.73B | $12.60B |
Free Cash Flow OCF − CapEx | $757.00M | $12.85B | $11.24B | $5.25B |
Shares Outstanding | 2.05B | 2.04B | 2.04B | 2.04B |